Table 1.
Parameter | No. of patients | % |
---|---|---|
Age (median, year) | 57 | 30–77 |
BMI (kg/m2) | 24.05 | 15.81–34.48 |
Gender | ||
Female | 64 | 67.4 |
Male | 31 | 32.6 |
Pathologic variables | ||
Adenocarcinoma | 95 | 100 |
Non‐adenocarcinoma | 0 | 0 |
Location of sample | ||
Primary lesion | 77 | 81.1 |
Metastatic lesion | 18 | 18.9 |
Smoking history | ||
Never smoked | 71 | 74.7 |
Ex‐smoker or current smoker | 24 | 25.3 |
Timing of treatment | ||
First‐line | 47 | 49.4 |
Subsequent | 48 | 50.5 |
Involvement of metastases sites | ||
Brain | 13 | 13.7 |
Liver | 8 | 8.4 |
Bone | 38 | 40 |
Adrenal | 4 | 4.2 |
Pulmonary | 41 | 43.2 |
Other sites | 41 | 43.2 |
EGFR mutation status | ||
18 | 2 | 2.1 |
19 | 49 | 51.6 |
20 | 13 | 13.7 |
21 | 44 | 46.3 |
BMI, body mass index; EGFR, epidermal growth factor receptor.